Search details
1.
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: a Randomized Controlled Trial.
Clin Gastroenterol Hepatol
; 2024 May 08.
Article
in English
| MEDLINE | ID: mdl-38729400
2.
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study.
Am J Gastroenterol
; 2024 Apr 11.
Article
in English
| MEDLINE | ID: mdl-38275272
3.
Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study.
Am J Gastroenterol
; 2024 Jan 26.
Article
in English
| MEDLINE | ID: mdl-38095692
4.
Ten missteps in the management of inflammatory bowel disease in Asia: An expert report by the Asian Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease.
J Gastroenterol Hepatol
; 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38725188
5.
Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding.
Gut
; 72(6): 1040-1053, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36944479
6.
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
Gastroenterology
; 163(4): 950-964, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35788348
7.
Microbial determinants of effective donors in faecal microbiota transplantation for UC.
Gut
; 2022 Jul 25.
Article
in English
| MEDLINE | ID: mdl-35879048
8.
Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial.
Clin Gastroenterol Hepatol
; 20(12): 2858-2867.e5, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35276329
9.
Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial.
Clin Gastroenterol Hepatol
; 20(2): 372-380.e2, 2022 02.
Article
in English
| MEDLINE | ID: mdl-33065307
10.
An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases.
J Gastroenterol Hepatol
; 37(2): 246-255, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34735024
11.
Tryptophan Metabolism 'Hub' Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease.
Int J Mol Sci
; 23(23)2022 Nov 26.
Article
in English
| MEDLINE | ID: mdl-36499104
12.
Assisted Reproductive Technology in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Am J Gastroenterol
; 116(12): 2334-2344, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34694245
13.
The Clinical Relevance of Manometric Esophagogastric Junction Outflow Obstruction Can Be Determined Using Rapid Drink Challenge and Solid Swallows.
Am J Gastroenterol
; 116(2): 280-288, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-33136563
14.
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.
Gut
; 69(5): 801-810, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32047093
15.
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(10): 2244-2255.e9, 2020 09.
Article
in English
| MEDLINE | ID: mdl-31816446
16.
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Gastroenterology
; 156(5): 1440-1454.e2, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30529583
17.
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments.
Gut
; 73(4): 712-714, 2024 Mar 07.
Article
in English
| MEDLINE | ID: mdl-36878683
18.
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).
Gut
; 68(1): 40-48, 2019 01.
Article
in English
| MEDLINE | ID: mdl-29247068
19.
Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced version.
J Gastroenterol Hepatol
; 34(1): 92-102, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30276858
20.
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.
J Gastroenterol Hepatol
; 34(8): 1296-1315, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-30848854